中
2024-07-28

經濟部產業技術司生技成果豐收 兩項抗癌產品完成授權

2024亞洲生技大展，經濟部產業技術司召開科專技術授權記者會，宣布兩項癌症醫療研發成果重大進展
2024-07-26

〈亞洲生技大會〉FLT3口服血癌抑制劑、癌症血液基因檢測授權技轉朗齊、列特博

BIO Asia-Taiwan 2024 亞洲生技大會隆重開幕，經濟部產業技術司今 (26) 日召開科專技術授權記者會，一是由生技中心專屬授權朗齊生醫 (6876-TW) 治療血癌之「新穎 FLT3 抑制劑血癌精準治療藥物」，另一為工研院「癌症高精準血液基因檢測」技轉列特博生技 (7725-TW)。
2024-07-26

經濟部產業技術司生技研發成果豐碩 推出新一代血癌藥物、癌症精準基因檢測領先國際

BIO Asia-Taiwan 2024亞洲生技大會隆重開幕，經濟部產業技術司今(26)日召開科專技術授權記者會，宣布兩項癌症醫療研發成果重大產業化進展
2024-05-10

列特博生技成棒隊孔令奇，榮獲113年全國成棒甲組春季聯賽打點獎

列特博生技成棒隊隊長「孔令奇」，於113年全國成棒甲組春季聯賽獲得「打點獎」，在本次賽會20場出賽共78打席，累積21分的打點紀錄，繼2023年爆米花聯盟奪得「打擊獎」後，表現再度獲得佳績。
2024-02-07

In February 2024, LabTurbo Company announced its application for a rights transfer case for domestic medical device manufacturers to comply with the medical device quality management system benchmark

In February 2024, LabTurbo Company announced its application for a rights transfer case for domestic medical device manufacturers to comply with the medical device quality management system benchmark inspection manufacturing license (license number QMS1339), and received a letter from the Ministry of Health and Welfare to allow it.
2023-08-15

LabTurbo AI0 48 obtained TFDA A.2570 clinical multi-standard detection system instrument IVD secondary medical material certification (Ministry of Health Medical Device Manufacturing No. 007604)

August 112
LabTurbo AI0 48 obtained TFDA A.2570 clinical multi-standard detection system instrument IVD secondary medical material certification (Ministry of Health Medical Device Manufacturing No. 007604)